Related references
Note: Only part of the references are listed.Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
M. F. Duarte et al.
AGING MALE (2019)
Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
Minyong Kang et al.
WORLD JOURNAL OF MENS HEALTH (2018)
Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
M. Fryczkowski et al.
DISEASE MARKERS (2018)
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer
Enrique Gomez-Gomez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
Vincenzo Serretta et al.
UROLOGY ANNALS (2018)
The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih et al.
NATURE REVIEWS UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Daniel Hormaechea-Agulla et al.
MOLECULAR CANCER (2017)
Adiponectin: Its role in obesity-associated colon and prostate cancers
Sntoshi Muppala et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Ghrelin and cancer progression
Tsung-Chieh Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease
Halina Grosman et al.
AGING MALE (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Obesity and cancer: mechanistic insights from transdisciplinary studies
Emma H. Allott et al.
ENDOCRINE-RELATED CANCER (2015)
In prostate cancer, low adiponectin levels are not associated with insulin resistance
Konstantinos Michalakis et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis
A. D. Raval et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Diagnostic Importance of Selected Protein Serum Markers in the Primary Diagnostics of Prostate Cancer
Otakar Capoun et al.
UROLOGIA INTERNATIONALIS (2015)
In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters
Raul M. Luque et al.
ONCOTARGET (2015)
Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
Heba Alshaker et al.
ONCOTARGET (2015)
In 1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
Alejandro Ibanez-Costa et al.
SCIENTIFIC REPORTS (2015)
Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer
Atsushi Ikeda et al.
PROSTATE INTERNATIONAL (2015)
Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study
Gabriel Y. Lai et al.
CANCER CAUSES & CONTROL (2014)
The Diagnostic Value of Adiponectin Multimers in Healthy Men Undergoing Screening for Prostate Cancer
Edward A. Medina et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
No Association of Plasma Levels of Adiponectin and c-peptide with Risk of Aggressive Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort
Victoria L. Stevens et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Obesity and cancer-mechanisms underlying tumour progression and recurrence
Jiyoung Park et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study
Mathilde Touvier et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study
Anya Burton et al.
CANCER CAUSES & CONTROL (2013)
Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer - Evidence of effect modification by prostate size
Jay H. Fowke et al.
CANCER LETTERS (2013)
Molecular Pathways: Adiponectin and Leptin Signaling in Cancer
Michael N. VanSaun
CLINICAL CANCER RESEARCH (2013)
Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - A cross-sectional study
Reshu Tewari et al.
CYTOKINE (2013)
Obesity and Prostate Cancer: Weighing the Evidence
Emma H. Allott et al.
EUROPEAN UROLOGY (2013)
Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin
Inge Seim et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2013)
Risk-Based Prostate Cancer Screening: Who and How?
Allison S. Glass et al.
CURRENT UROLOGY REPORTS (2013)
Prostate cancer epidemiology in the United States
Otis W. Brawley
WORLD JOURNAL OF UROLOGY (2012)
Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
Joep G. H. van Roermund et al.
BJU INTERNATIONAL (2011)
Leptin increases prostate cancer aggressiveness
Constanza M. Lopez Fontana et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
Manuel D. Gahete et al.
PLOS ONE (2011)
Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer
Halina Grosman et al.
AGING MALE (2010)
Serum leptin: A marker of prostate cancer irrespective of obesity
S. K. Singh et al.
CANCER BIOMARKERS (2010)
A 25-Year Prospective Study of Plasma Adiponectin and Leptin Concentrations and Prostate Cancer Risk and Survival
Haojie Li et al.
CLINICAL CHEMISTRY (2010)
Serum Adipocytokine Levels in Prostate Cancer Patients
Elif Damla Arisan et al.
UROLOGIA INTERNATIONALIS (2009)
Elevated Blood Active Ghrelin and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate Carcinoma
Witold Malendowicz et al.
UROLOGIA INTERNATIONALIS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Relationship between serum adiponectin and prostate cancer grade
David J. Sher et al.
PROSTATE (2008)
Obesity and prostate cancer: Epidemiology and clinical implications
W. Cooper Buschemeyer et al.
EUROPEAN UROLOGY (2007)
Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake
Naoto Kubota et al.
CELL METABOLISM (2007)
Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden
Tanja Stocks et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study
Konstantinos Michalakis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Obesity, adipokines, and prostate cancer in a prospective population-based study
Jacques Baillargeon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex
Yu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Molecular interactions of leptin and prostate cancer
Radhika Gade-Andavolu et al.
CANCER JOURNAL (2006)
Assessing prostate cancer risk: Results from the prostate cancer prevention trial
IM Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy
SJ Freedland et al.
JOURNAL OF UROLOGY (2005)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Leptin influences cellular differentiation and progression in prostate cancer
K Saglam et al.
JOURNAL OF UROLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Prostate cancer risk and serum levels of insulin and leptin: a population-based study
AW Hsing et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Circulating Ghrelin levels are decreased in human obesity
M Tschöp et al.
DIABETES (2001)
Share Paper
